Showing results (121-130 of 148) with videos related to
Sort By:
Pageof 15
Molecular and Cellular Biology|June 1, 1994
The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesodermA Bhushan, H Y Lin, H F Lodish, et al.Acta Biochimica Polonica|January 1, 1995
Aza and diaza bioisosteric anthracene-9,10-diones as antitumor agentsA P Krapcho, M J Maresch, M P Hacker, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndromeA Bhushan, B Barnhart, S Shone, et al.Journal of Medicinal Chemistry|August 1, 1986
Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systemsA P Krapcho, J J Landi, K J Shaw, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
Increased systemic, but not regional, neopterin production following intraperitoneal administration of interleukin-2 and lack of effect of pterins upon the lymphokine-activated killer cell phenomenonJ D Roberts, J C Bigelow, A L Moore, et al.Biochemistry|May 20, 1986
A Raman spectroscopic study of hen egg yolk phosvitin: structures in solution and in the solid stateB Prescott, V Renugopalakrishnan, M J Glimcher, et al.Immunology|January 29, 2000
A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactionsB Barnhart, G S Ford, A Bhushan, et al.International Journal of Oncology|April 30, 2011
Differential mechanisms of multidrug resistance are expressed during stepwise selection of KB-3-1 cells with adriamycinL Villagra, A Darling, D Yassa, et al.Journal of Medicinal Chemistry|August 11, 1991
Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-dionesA P Krapcho, Z Getahun, K L Avery, et al.Biochemical Pharmacology|January 24, 1997
Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activityS C Wong, R McQuade, S A Proefke, et al.Pageof 15